Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - KEMPHARM, INC | kmph20201231_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - KEMPHARM, INC | ex_219889.htm |
| EX-32.1 - EXHIBIT 32.1 - KEMPHARM, INC | ex_219888.htm |
| EX-31.2 - EXHIBIT 31.2 - KEMPHARM, INC | ex_219887.htm |
| EX-31.1 - EXHIBIT 31.1 - KEMPHARM, INC | ex_219886.htm |
| EX-10.8 - EXHIBIT 10.8 - KEMPHARM, INC | ex_233334.htm |
| EX-4.8 - EXHIBIT 4.8 - KEMPHARM, INC | ex_219883.htm |
| EX-4.2 - EXHIBIT 4.2 - KEMPHARM, INC | ex_227827.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (No. 333-234235, No. 333-252078 and No. 333-252903) on Form S-3 and Registration Statements (No. 333-203703, No. 333-210369, No. 333-216858, No. 333-224062, No. 333-230041, No. 333-236794 and No. 333-252743) on Form S-8 of KemPharm, Inc. of our report dated March 11, 2021 relating to the financial statements of KemPharm, Inc., appearing in this Annual Report on Form 10-K of KemPharm, Inc. for the year ended December 31, 2020.
/s/ RSM US LLP
Orlando, Florida
March 11, 2021